BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11229301)

  • 1. Quinolone resistant enteric fever--problems and remedies.
    Rodrigues C; Mehta A; Joshi VR
    J Assoc Physicians India; 1998 Aug; 46(8):751-2. PubMed ID: 11229301
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH; Khan MA
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone resistance in Salmonella Typhi.
    Cooke FJ; Wain J; Threlfall EJ
    BMJ; 2006 Aug; 333(7563):353-4. PubMed ID: 16902221
    [No Abstract]   [Full Text] [Related]  

  • 4. Enteric fever treatment failures: a global concern.
    Chandel DS; Chaudhry R
    Emerg Infect Dis; 2001; 7(4):762-3. PubMed ID: 11585550
    [No Abstract]   [Full Text] [Related]  

  • 5. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
    Al-Khuwaitir TS; Al-Zuhair AA; Al-Ghamdi AG; Khan A
    Saudi Med J; 2008 Jan; 29(1):129-32. PubMed ID: 18176688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloramphenicol-resistant enteric fever.
    Avasthi R; Kataria SP; Agarwal MP
    J Assoc Physicians India; 1992 Mar; 40(3):208. PubMed ID: 1634496
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C; Mehta A; Andrews R; Joshi VR
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract]   [Full Text] [Related]  

  • 10. Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?
    Kadhiravan T; Wig N; Renuka K; Kapil A; Kabra SK; Misra A
    J Med Microbiol; 2008 Aug; 57(Pt 8):1046-1048. PubMed ID: 18628512
    [No Abstract]   [Full Text] [Related]  

  • 11. Typhoid fever: narrowing therapeutic options in India.
    Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
    Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
    Prabha Adhikari MR; Baliga S
    J Assoc Physicians India; 2002 Mar; 50():428-9. PubMed ID: 11924574
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
    Bandyopadhyay R; Balaji V; Yadav B; Jasmine S; Sathyendra S; Rupali P
    Trop Doct; 2018 Jul; 48(3):182-188. PubMed ID: 29495943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM; Seema DS; Bhat GK; Shivananda PG
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract]   [Full Text] [Related]  

  • 15. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
    Asna SM; Haq JA; Rahman MM
    Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinolone resistant typhoid outbreak in an extended joint family.
    Rajeev A
    J Commun Dis; 1999 Dec; 31(4):263-5. PubMed ID: 10937306
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloramphenicol-resistant enteric fever.
    Mehta PJ
    J Assoc Physicians India; 1982 Apr; 30(4):196. PubMed ID: 7182385
    [No Abstract]   [Full Text] [Related]  

  • 18. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
    [No Abstract]   [Full Text] [Related]  

  • 19. Nalidixic acid-resistant Salmonella typhi in Mumbai.
    Rodrigues C; Mehta A; Joshi VR
    Natl Med J India; 1999; 12(2):88. PubMed ID: 10416332
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging drug resistance and vaccination for typhoid fever.
    Atkins BL; Gottlieb T
    JAMA; 1998 Feb; 279(8):579; author reply 580. PubMed ID: 9486743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.